Variability in eosinophil levels at start of severe exacerbations of COPD

E. Citgez (Enschede, Netherlands), J. Van Der Palen (Enschede, Netherlands), P. Van Der Valk (Enschede, Netherlands), H. Kerstjens (Groningen, Netherlands), M. Brusse-Keizer (Enschede, Netherlands)

Source: Virtual Congress 2020 – Diagnosis and management of COPD
Session: Diagnosis and management of COPD
Session type: E-poster session
Number: 100
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Citgez (Enschede, Netherlands), J. Van Der Palen (Enschede, Netherlands), P. Van Der Valk (Enschede, Netherlands), H. Kerstjens (Groningen, Netherlands), M. Brusse-Keizer (Enschede, Netherlands). Variability in eosinophil levels at start of severe exacerbations of COPD. 100

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of the eosinophil variability on severe exacerbations in an asthmatic population
Source: Virtual Congress 2020 – Severe asthma phenotypes and outcomes
Year: 2020




Relationship of blood eosinophil count to exacerbations in COPD
Source: International Congress 2016 – Airway response to infection
Year: 2016


Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016


Change of induced sputum TNF-a and sTNF-R55,75 levels in patients with acute exacerbations of COPD
Source: Annual Congress 2007 - Respiratory pathophysiology
Year: 2007


Change in inflammation during COPD exacerbations
Source: Eur Respir J 2005; 26: Suppl. 49, 15s
Year: 2005

Correlations between exacerbation rate and blood eosinophil levels in COPD patients
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017

Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018



Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016

Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients.
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020


Circulating eosinophil levels do not predict severe exacerbations in COPD: a retrospective study
Source: ERJ Open Res, 4 (3) 00022-2018; 10.1183/23120541.00022-2018
Year: 2018



Neutrophil elastase in severe COPD and asthma exacerbation
Source: Eur Respir J 2006; 28: Suppl. 50, 36s
Year: 2006

Relationship of blood eosinophil count to exacerbations in asthma patients with a COPD diagnosis
Source: International Congress 2015 – Epidemiological studies of asthma and allergy
Year: 2015


Peripheral neutrophil stiffness is increased in COPD severe exacerbations
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012


The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020


Changes in the induced sputum proteome during COPD exacerbations
Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases
Year: 2020


Effect of lower airway bacterial colonisation on time to acute exacerbation in patients with COPD
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015

The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013

Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013

Effect of COPD exacerbations on early lung function decline under maintenance therapy: blood eosinophil count asbiomarker
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019




Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019